Skip to the page

Data / Medical devices / Ireland / Therakos Development Limited

Therakos Development Limited: FDA-registered device maker in Blanchardstown Dublin(County), Ireland, 1 PMA approval

Therakos Development Limited is registered with the FDA (registration 3036773437) in Blanchardstown Dublin(County), Ireland. It lists 1 device type. The FDA files 1 PMA approval under its listings, the newest dated April 8, 1987. 1 recall event names it as the recalling firm. Registered through 2027. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3036773437
Address
Suite 1 Plaza 211, Blanchardstown Corporate Park 2 Blanchardstown Road North, Blanchardstown Dublin(County), Ireland, D15 AP2D
Owner or operator
Therakos Development Limited (10092738)
Roles
Complaint file establishment, Specification developer
First device listed
February 12, 2025
Registered through
2027
Brand names listed
THERAKOS CELLEX

Devices it lists

DeviceProduct codeClassRoleSource
System, Photopheresis, ExtracorporealLNR3Complaint file establishment, Specification developeraccessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
April 8, 1987P860003UVAR PHOTOPHERESIS SYSTEMLNR107November 21, 2025accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
May 16, 202598558Class IIOngoingBrand Name: Cellex Photopheresis System Product Name: CELLEX Photopheresis Kit Model/Catalog Number: CLXUSA Software Version: Not Applicable Product Description: THERAKOS Photopheresis or extracorporeal photopheresis (ECIncreased difficulty in installing the centrifuge bowl onto the centrifuge bowl holder. Improper installation may cause the centrifuge bowl to dislodge, resulting in a broken bowl during the prime cycle or treatment phase, leading to a delay in patient treatment and blood loss.accessdata.fda.gov

Compare with other makers

Updated April 16, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.